Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080871 · ClinicalTrials.gov registry record · NA
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
A NA study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT02080871 is a NA study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 134 participants.
The verdict
NCT02080871, a NA study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
Evaluation of the Gore(R) VIABAHN BX for the treatment of arterial occlusive disease in the common and/or external iliac arteries.
Interventions
- DEVICE Stenting of the Common and/or External Iliac Arteries
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02080871
The ClinicalTrials.gov registry entry for NCT02080871 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stenting of the Common and/or External Iliac Arteries is the first listed.
NCT02080871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02080871 about?
NCT02080871 is a clinical study titled "A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.". Evaluation of the Gore(R) VIABAHN BX for the treatment of arterial occlusive disease in the common and/or external iliac arteries.
What is the current status of trial NCT02080871?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2014-07. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02080871?
The interventions under investigation include: Stenting of the Common and/or External Iliac Arteries (DEVICE).
Who is sponsoring clinical trial NCT02080871?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.